Sort
39,280 grants matching “leukemia”
Restoration of Tumor Suppression Activity in Malignant Melanoma
$486,085David Joseph Weber · University Of Maryland Baltimore · R01 · FY2007 · CA
Metabolic Syndrome Following Transplant for Leukemia
$486,075Kevin S Baker · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
TARGETING AML-STROMAL INTERACTIONS
$486,043John F Dipersio · Washington University · R01 · FY2014 · CA
Functional Networks for Persister Cell Sensitivities
$486,023Michael T McManus · University Of California, San Francisco · R01 · FY2017 · CA
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2019 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2021 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2023 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2022 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2020 · AI
Developmental Therapeutics
$485,980Guido J. Tricot · Univ Of Arkansas For Med Scis · P01 · FY2007 · CA
Glucocorticoids in Lymphoblastic Leukemia
$485,955Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2016 · CA
FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS
$485,894Beerelli Seshi · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R33 · FY2008 · CA
The role of Pleckstrin-2 as a functional node in myeloid proliferation
$485,879Peng Ji · Northwestern University At Chicago · R01 · FY2021 · HL
Mechanisms of targeting cellular self-renewal in glioblastoma
$485,837Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
RNA Nanotechnology in Cancer Therapy
$485,825Peixuan Guo · University Of Cincinnati · U01 · FY2010 · CA
Structure-function studies of single transmembrane helix receptors
$485,809Steven Owen Smith · State University New York Stony Brook · R01 · FY2011 · GM
Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms
$485,801Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · HL
Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD
$485,790Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · CA
Ethnic Differences in Survival after Childhood ALL
$485,753Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2007 · CA
Lymphomas And Retroviral Pathogenesis
$485,747Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Lymphomas And Retroviral Pathogenesis
$485,745Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Mechanism and therapeutic opportunities of targeting the Tudor domain
$485,717Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Heme synthesis, use and trafficking during erythropoiesis
$485,711Janis L Abkowitz · University Of Washington · R01 · FY2022 · HL
Heme synthesis, use and trafficking during erythropoiesis
$485,711Janis L Abkowitz · University Of Washington · R01 · FY2023 · HL
Transporters and hematopoietic toxicity
$485,573John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2017 · CA